← Back to Search

Pranayama for Hypertension in Pregnancy

N/A
Recruiting
Led By Shilpa Babbar, MD
Research Sponsored by Children's Mercy Hospital Kansas City
Eligibility Criteria Checklist
Specific guidelines that determine who can or cannot participate in a clinical trial
Must have
Phase II Only- Gestational hypertension - defined as elevated blood pressure (Systolic blood pressure greater than or equal to 140 mmHg and /or a diastolic blood pressure greater than or equal to 90 mmHg) after 20 weeks of pregnancy without any evidence of end-organ damage or proteinuria, with or without antihypertensive use
Be older than 18 years old
Must not have
Have difficulty or cannot breathe through their nose
Known deviated nasal septum
Timeline
Screening 3 weeks
Treatment Varies
Follow Up one visit, 15 minute intervention
Awards & highlights
No Placebo-Only Group

Summary

This trial will test the effects of different deep breathing techniques on blood pressure during pregnancy.

Who is the study for?
This trial is for English-speaking pregnant women over 18 years old in their third trimester with high blood pressure, either gestational hypertension or chronic hypertension without severe features. It's not for those needing urgent delivery, with pre-eclampsia concerns, severe lung disease, deviated nasal septum, difficulty breathing through the nose, or very low blood pressure.
What is being tested?
The study tests how Alternate Nostril Breathing, Bhramari Breathing, and Sheetali Breathing affect blood pressure during pregnancy. It also looks at other physiological parameters like heart rate and respiratory rate to see if these yogic techniques can naturally reduce them.
What are the potential side effects?
Since this trial involves non-invasive breathing exercises from yoga practices rather than medication or surgery, side effects are minimal but may include discomfort due to breath control or dizziness.

Eligibility Criteria

Inclusion Criteria

You may be eligible if you check “Yes” for the criteria below
Select...
I have high blood pressure during pregnancy without organ damage.

Exclusion Criteria

You may be eligible for the trial if you check “No” for criteria below:
Select...
I have trouble breathing through my nose.
Select...
I have a deviated septum.
Select...
I have an ongoing or recent lung condition.
Select...
I have a severe lung condition.

Timeline

Screening ~ 3 weeks
Treatment ~ Varies
Follow Up ~one visit, 15 minute intervention
This trial's timeline: 3 weeks for screening, Varies for treatment, and one visit, 15 minute intervention for reporting.

Treatment Details

Study Objectives

Study objectives can provide a clearer picture of what you can expect from a treatment.
Primary study objectives
Hypertensive disease
Secondary study objectives
Change in body temperature from baseline to after the intervention
Change in cardiac output from baseline to after the intervention
Change of heart rate from baseline to after the intervention

Awards & Highlights

No Placebo-Only Group
All patients enrolled in this study will receive some form of active treatment.

Trial Design

6Treatment groups
Active Control
Group I: Sheetali Breathing Phase IIActive Control1 Intervention
Sheetali breathing for hypertensive women in 3rd trimester of pregnancy
Group II: Sheetali Breathing Phase IActive Control1 Intervention
Sheetali breathing for normotensive women in 3rd trimester of pregnancy
Group III: Alternate Nostril Breathing Phase IIActive Control1 Intervention
Alternate nostril breathing for hypertensive women in 3rd trimester of pregnancy
Group IV: Alternate Nostril Breathing Phase IActive Control1 Intervention
Alternate nostril breathing for normotensive women in 3rd trimester of pregnancy
Group V: Bhramari Breathing Phase IActive Control1 Intervention
Bhramari breathing for normotensive women in 3rd trimester of pregnancy
Group VI: Bhramari Breathing Phase IIActive Control1 Intervention
Bhramari breathing for hypertensive women in 3rd trimester of pregnancy

Find a Location

Who is running the clinical trial?

Children's Mercy Hospital Kansas CityLead Sponsor
256 Previous Clinical Trials
940,245 Total Patients Enrolled
Shilpa Babbar, MDPrincipal InvestigatorChildren's Mercy Hospital Kansas City
2 Previous Clinical Trials
46 Total Patients Enrolled

Media Library

Alternate Nostril Breathing Clinical Trial Eligibility Overview. Trial Name: NCT05341921 — N/A
Hypertension Research Study Groups: Sheetali Breathing Phase II, Sheetali Breathing Phase I, Alternate Nostril Breathing Phase II, Alternate Nostril Breathing Phase I, Bhramari Breathing Phase I, Bhramari Breathing Phase II
Hypertension Clinical Trial 2023: Alternate Nostril Breathing Highlights & Side Effects. Trial Name: NCT05341921 — N/A
Alternate Nostril Breathing 2023 Treatment Timeline for Medical Study. Trial Name: NCT05341921 — N/A
~19 spots leftby Jul 2025